CClinicalTrials.gg
Active, not recruitingNCT04122248Updated Jul 30, 2025

M6-C Post Approval Study (PAS)

An observational study in Cervical Degenerative Disc Disease, Cervical Radiculopathy and Cervical Spinal Cord Compression, sponsored by Spinal Kinetics. Active, not recruiting at 21 sites in United States. Open to participants aged 21 Years to 68 Years. Per ClinicalTrials.gov, last updated 2025-07-30.

Sponsored by Spinal Kinetics · Observational

From the registry’s dates

  • Primary completion was expected by Jun 2026, 3 months ago, but the record still lists the study as active, not recruiting.
Study type
Observational
Model
Cohort
Time perspective
Prospective
Enrollment
152
Ages
21 Years to 68 Years
Sex
All
01

Study summary

The M6-C Post Approval Study is a long term follow-up study of subjects previously enrolled and treated in the M6-C Artificial Cervical Disc IDE Study.

Read the detailed description

A prospective, concurrently controlled, multi-center pivotal study to evaluate the safety and effectiveness of the M6-C™ Artificial Cervical Disc compared to anterior cervical discectomy and fusion (ACDF) was performed in the United States under IDE #G050254. To fulfill the concurrent control design of the study, there were clinical sites that evaluated the safety and effectiveness of the M6-C™ Artificial Cervical Disc and there were other clinical sites that evaluated ACDF. Subjects in the study were treated between May 2014 and June 2016 and remain in follow-up. The M6-C™ Artificial Cervical Disc received FDA approval to market on February 6, 2019. As a condition of approval, the FDA requested that the sponsor perform a post market approval study (PAS). The subjects enrolled and remaining in the M6-C IDE pivotal study are the prospective patient population for the PAS.

02

Conditions studied

  • Cervical Degenerative Disc Disease
  • Cervical Radiculopathy
  • Cervical Spinal Cord Compression
  • Cervical Disc Herniation

Browse trials for

Keywords

  • artificial cervical disc arthroplasty
03

In context

Radiculopathy

488 studies on the registry are indexed under Radiculopathy; 141 are open to participants now.

This study's enrollment of 152 is above the median of 93 across 98 observational studies indexed under Radiculopathy.

Browse Radiculopathy studies →

Lead sponsor

Spinal Kinetics is the lead sponsor of 2 studies on the registry; none are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
21 Years to 68 Years
Sexes eligible
All
Accepts healthy volunteers
No
Sampling method
Probability sample

Study population

Subjects eligible for study enrollment will include subjects implanted in the M6-C™ IDE pivotal study

Inclusion criteria

  • Since the subjects have already been screened as part of the IDE's pivotal study, and only subjects that participated in that study make up the subject cohort for this long-term follow-up study, there are no additional inclusion criteria

Exclusion criteria

Exclusion Criteria:

  • Subjects who were withdrawn or withdrew consent to participate in the investigation
  • Subjects who do not consent to participate in long-term follow-up or provide personal contact information to the sponsor (solely for the purposes of tracking subjects to help ensure follow-up compliance)
  • Patients with terminal failures (SSI or device- or procedure-related SAE) by Month 24 and all known patient deaths in the M6-C IDE study are excluded for enrollment into the PAS
05

Study design

Observational model
Cohort
Time perspective
Prospective
Enrollment
152 participants (actual)
Patient registry
No

Groups and cohorts

  • M6-C

    Subjects treated with an M6-C device

    Other: standard radiographic imaging · Device: cervical total disc replacement

  • ACDF

    Subjects treated with Anterior Cervical Discectomy and Fusion (ACDF)

    Other: standard radiographic imaging

Interventions

  • Otherstandard radiographic imaging

    standard radiographic imaging

  • Devicecervical total disc replacement

    Artificial disc replacement (ADR) in the cervical spine is a minimally invasive procedure that involves removing diseased disc tissue and replacing it with an artificial disc. The artificial disc is designed to preserve the spine\'s natural motion while remaining securely attached to the surrounding vertebral bones. The goal of ADR is to help preserve the motion of the cervical spine or spinal segment after surgery, which can improve the quality of life for patients.

    Also known as: cervical disc arthroplasty, cervical artificial disc replacement

06

What researchers measure

Primary outcomes

  1. Overall subject success

    A study subject will be considered an overall success if he/she meets the following criteria: * No serious adverse event(s) classified as device or device procedure related (as determined by the CEC), and * No subsequent surgical procedure at the index level (including revision, removal, reoperation, or supplemental fixation), and * Maintenance or improvement in neurological function, and * Improvement on the NDI of at least 15 points.

    Time frame: 10 year follow-up

Secondary outcomes

  1. Neck Disability Index (NDI)

    The NDI is a patient reported outcome questionnaire for the measurement of pain and function related to cervical spine problems. A total NDI score is determined by adding the scores of the individual questions and dividing that total by the maximum possible score (i.e., 50 if all questions are answered) to yield a percentage. Therefore, the NDI score ranges from 0% to 100%. A lower score represents less pain and dysfunction.

    Time frame: annually to 10 years

  2. Neck and arm pain

    A visual analogue scale is a patient reported outcome measure utilized to determine neck and arm pain on a zero to ten scale with zero being the least amount of pain and 10 the most possible pain.

    Time frame: annually to 10 years

  3. SF-36 Health Survey

    The SF-36 is a patient reported outcome questionnaire to measure health-related Quality of Life. An increase in score from baseline represents an improvement in health.

    Time frame: annually to 10 years

  4. Patient Satisfaction

    The following 5 point Likert Scale will be used to further assess subject satisfaction: 1. How satisfied are you with the results of your surgery? Very Satisfied; Satisfied; Neutral; Unsatisfied; Very Unsatisfied 2. All things considered, would you have the surgery again? Very likely; likely; not sure; Unlikely; Very Unlikely 3. Would you recommend the surgery to a friend or family member? Very likely; likely; not sure; Unlikely; Very Unlikely

    Time frame: annually to 10 years

  5. Odom's Criteria

    At the 5, 7 and 10 year follow-up visits, the Investigator will rate the clinical disposition of each study subject according to Odom's Criteria\[18\] as follows: Excellent: No symptoms related to cervical disease. Able to perform daily activities without limitations. Good: Moderate symptoms related to cervical disease. Able to perform daily activities without significant limitations. Satisfactory: Slight improvement is symptoms related to cervical disease. Significant limitations in daily activities. Poor: No improvement in, or aggravation of, symptoms related to cervical disease. Not able to perform daily activities.

    Time frame: annually to 10 years

07

Study locations

21 sites
  • Desert Institute for Spine Care
    Phoenix, Arizona 85020, United States
  • The CORE Institute
    Sun City West, Arizona 85375, United States
  • Spine MD
    Beverly Hills, California 90210, United States
  • Memorial Orthopedic Surgical Group
    Long Beach, California 90806, United States
  • Stanford University
    Stanford, California 94305, United States
  • University of Colorado School of Medicine
    Aurora, Colorado 80045, United States
  • ClinTech Center for Spine
    Johnstown, Colorado 80534, United States
  • Yale University School of Medicine
    New Haven, Connecticut 06519, United States
  • Medstar Hospital/Georgetown University
    Washington D.C., District of Columbia 20007, United States
  • Midwest Orthopedics
    Chicago, Illinois 60612, United States
  • Indiana Spine Group
    Carmel, Indiana 46032, United States
  • Spine Institute of Lousianna
    Shreveport, Louisiana 71101, United States
  • HSS
    New York, New York 10021, United States
  • Upstate Medical University
    Syracuse, New York 13057, United States
  • CNSA
    Charlotte, North Carolina 28204, United States
  • OrthoCarolina Research Institute
    Charlotte, North Carolina 28207, United States
  • EmergeOrtho
    Durham, North Carolina 27704, United States
  • The Ohio State University - Wexner Medical Center
    Columbus, Ohio 43202, United States
  • Center for Sports Medicine & Orthopedics
    Chattanooga, Tennessee 37404, United States
  • Texas Back Institute
    Plano, Texas 75093, United States
  • West Virginia University
    Morgantown, West Virginia 26506, United States
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Jul 30, 2025, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT04122248
Lead sponsor
Spinal Kinetics
Responsible party
Sponsor
First posted
Oct 10, 2019
Start date
Nov 30, 2019
Primary completion
Jun 30, 2026 (estimated)
Completion
Jun 30, 2026 (estimated)
Last update
Jul 30, 2025

Oversight

Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
Yes
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is active, not recruiting, as verified in Jul 2025. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion